Study S001295

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05819138
Acronym: T1-DISCO
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: TRIPLE
Status: RECRUITING
Enrollment: 60
Start: 2023-06-21
Primary completion: 2027-10-01
Lead sponsor: University of Colorado, Denver
Conditions: Diabetes Mellitus, Type 1
Interventions: DRUG:Semaglutide Pen Injector; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:R01HL165433

Registered primary outcomes

Change in Ascending Aortic Pulse Wave Velocity (AA PWV) [Baseline, month 8]
Change in Carotid and Femoral Artery Pulse Wave Velocity (CF-PWV) [Baseline, month 8]
Change in Carotid and Radial Artery Pulse Wave Velocity (CR-PWV) [Baseline, month 8]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.